|
Jan 4
|
AbbVie Inc. (NYSE:ABBV) is largely controlled by institutional shareholders who own 73% of the company
|
|
Jan 4
|
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
|
|
Jan 3
|
AbbVie to Host Full-Year and Fourth-Quarter 2024 Earnings Conference Call
|
|
Jan 3
|
The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer
|
|
Jan 2
|
What RFK Jr.’s Dislike for Drug TV Commercials Could Mean for the Ad Industry
|
|
Jan 2
|
5 Large Drug Stocks to Keep An Eye On in the New Year
|
|
Jan 1
|
Drug-Trial Results Could Shake Up Pharma Stocks in 2025. Watch Eli Lilly, Pfizer, and More.
|
|
Dec 31
|
AbbVie (ABBV) Gains As Market Dips: What You Should Know
|
|
Dec 31
|
AbbVie (ABBV) Upgraded to Buy: What Does It Mean for the Stock?
|
|
Dec 31
|
10 stocks retail investors craved in 2024
|
|
Dec 31
|
Are Medical Stocks Lagging Anavex Life Sciences (AVXL) This Year?
|
|
Dec 31
|
Brokers Suggest Investing in AbbVie (ABBV): Read This Before Placing a Bet
|
|
Dec 31
|
Is AbbVie Inc. (ABBV) the Best Dividend Stock of 2024?
|
|
Dec 30
|
Is AbbVie Inc. (ABBV) the Best Pharma Dividend Stock to Buy In 2024?
|
|
Dec 30
|
Is AbbVie Inc. (ABBV) the Best Stock for 10 Years?
|
|
Dec 30
|
Credit Spreads Haven’t Looked This Good Since the 2000s. Can They Get Better?
|
|
Dec 30
|
Is AbbVie Inc. (ABBV) the Best Dividend Growth Stock to Buy and Hold in 2025?
|
|
Oct 3
|
AbbVie (ABBV) Suffers a Larger Drop Than the General Market: Key Insights
|
|
Oct 3
|
AbbVie cuts 2024 profit forecast citing R&D expenses
|
|
Oct 3
|
Blue Shield of California Slashes Humira Biosimilar Prices in Landmark Deal
|